SCHEMBL17640610

SCHEMBL17640610

c1ccc(-c2ccc(-c3ccc(-c4nsc(-c5ccccc5)n4)cc3)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.66
MAPT P10636 3/20 0.62
HSD17B1 P14061 2/20 0.57
HSD17B2 P37059 2/20 0.57
ADORA3 P0DMS8 4/20 0.57
ADORA2A P29274 2/20 0.57
ADORA2B P29275 2/20 0.57
ADORA1 P30542 2/20 0.57
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
MEN1 O00255 1/20 0.50
CASP3 P42574 1/20 0.50
KMT2A Q03164 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
SNCA P37840 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2212694 0.96 CYP19A1 (0.67) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL28406599 0.89 CYP19A1 (0.58) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL28400538 0.89 CYP19A1 (0.58) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL19196280 0.86 HSD17B1 (0.62) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL17570194 0.86 HSD17B1 (0.66) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL17570204 0.86 HSD17B1 (0.66) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL21915258 0.86 CYP19A1 (0.54) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL713663 0.85 CYP19A1 (0.55) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL19131313 0.84 CYP19A1 (0.57) CYP19A1MAPTHSD17B1HSD17B2ADORA3
SCHEMBL28397538 0.84 ADORA3 (0.56) CYP19A1MAPTHSD17B1HSD17B2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 CYP19A1 2245/4885MAPT 2708/4885HSD17B1 1405/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 CYP19A1 2245/4885MAPT 2708/4885HSD17B1 1405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.